Synbio Technologies is incorporated with a single mission in mind to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis) and DNA editing (engineering) capabilities and delivered satisfactory solutions to global researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding and biofuel implication etc.